Multiple Sclerosis: Disease Overview and Management Strategies

Disease Essentials

MS is a chronic, immune-mediated demyelinating disease of the CNS (brain, spinal cord, optic nerves). Peak onset 20–40 years; 3:1 female predominance.

Therapeutic Pillars

  1. Disease-modifying therapies (DMTs): Reduce relapse rate, new MRI lesions, disability progression. Options: injectables (interferons, glatiramer), oral (fingolimod, dimethyl fumarate, teriflunomide, siponimod), infusions (natalizumab, ocrelizumab, alemtuzumab). Selection by phenotype, risk tolerance, comorbidities.
  2. Relapse management: High-dose IV methylprednisolone ± plasma exchange.
  3. Symptomatic treatment: Spasticity (baclofen, tizanidine), fatigue (amantadine, modafinil), neuropathic pain (gabapentin, duloxetine), bladder/bowel, depression, cognitive rehab.
  4. Rehabilitation: PT, OT, speech/swallow therapy, vocational counseling.
  5. Lifestyle: Vitamin D optimization, smoking cessation, exercise, heat avoidance.

Multidisciplinary MS centers optimize outcomes. No cure yet, but early DMT use improves long-term prognosis.

Multiple Sclerosis - Related Articles